Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
4 February 2016
Header
Header image
News

News

Vietnam Free Trade Agreement Will Boost Access to Medicines
03 February 2016

EFPIA welcomes the publication of the EU-Vietnam Free Trade Agreement text, which provides a strong precedent for future FTAs in the region. EFPIA is furthermore grateful to the [...] Read more

From our blog

From our blog

WEB-RADR, IMI’s Reporting App, Expands Its European Footprint
04 February 2016 by Magda Chlebus

After taking off in the UK, WEB-RADR, a revolutionary means of reporting adverse incidents, is expanding its presence across Europe. The WEB-RADR app – an integral element of the WEB-RADR project and itself part of the Innovative Medicines Initiative –which makes reporting significantly easier for patients, carers and healthcare professionals alike, has now been launched in the Netherlands.

Read more

From our blog

Cancer Prevention and Control: a Case of Policy, Science and Economics
04 February 2016 by Magda Chlebus

If there is a single disease that strikes terror into the hearts of those who hear its name, it is undoubtedly cancer. With more than one and a quarter million people dying from cancer in the EU-28 in 2012 – just over one quarter (25.8 %) of the total number of deaths – it’s easy to see why.

Read more

From our blog

The EU-Vietnam FTA: a triumph in putting patients first
04 February 2016 by Jan Rask Christensen

The recently published text of the FTA between Vietnam and the EU brings a number of benefits to Vietnamese patients and to the innovative pharmaceutical industry. This positive outcome for the pharmaceutical industry has to a large extent been enabled through close cooperation between EFPIA and the local trade association in Vietnam, Pharma Group.

Read more

Videos

Video

EFPIA DG Lecture - Innovators or Speculators? Price, value and access to medicines in Europe, 1 December 2015

This video includes highlights from the EFPIA DG Lecture "Innovators or Speculators? - Price, value and access to medicines in Europe", which was held on 1 December 2015, in Brussels.

View video

Events calendar

Events Calendar

EFPIA Annual Conference 2016
On 15/06/2016 (Radisson Hotel, Brussels)

This year's EFPIA Annual Conference will take place on 15 June 2016, at the Radisson Hotel in Brussels. The event will examine the challenges faced by healthcare systems in Europe, the exciting science that will play a key role in meeting these challenges and the long-term sustainability of healthcare delivery. An interactive exhibition will be set up to provide attendees with further insight into EFPIA’s current initiatives, which aim at facilitating a pan-European dialogue on the importance of shifting towards a model of outcomes-driven healthcare.
 
The final programme can be accessed here
 
Read more

Events Calendar

2016 China/EU Pharmaceutical Industry Forum
On 05/04/2016 (Hamburg, Germany)

CPIA and EFPIA will organise a workshop on 5 April 2016, in Hamburg, Germany, with the following areas of focus: an overview of the pharmaceutical market in China/EU; Pharmaceuticals in the Environment; the Drug Administration Law (DAL) revision; and the implementation of new EU legislation. 

The workshop takes place the day before the start of the DIA Euro meeting, which will facilitate for those who already plan to attend the DIA Euro meeting in Hamburg.
 
This will be an excellent opportunity to listen to e.g. a presentation on the revision of the Drug Administration Law in China and the European Commission strategy for Pharmaceuticals in the Environment (PIE) and also get direct information from the Commission on what will happen in 2019 re Identification and authentication of medicines in Europe as a result of the implementation of the Falsified Medicines Directive.
 
Please see the programmme for further details. Below, you can access the speakers' presentations:
 
European Commission strategy for Pharmaceuticals in the Environment (PIE), Patrizia Tosetti, Medical products: quality, safety, innovation, European Commission
 
 
Read more

Events Calendar

Inaugural Conference of the European Institute for Innovation through Health Data (i~HD)
On 10/03/2016 (Paris, France)

This Inaugural Conference will mark the parallel launch of a novel European platform to support multi-centre clinical research. This operational platform, the result of the European project EHR4CR (Electronic Health Records for Clinical Research), can connect securely to the data within multiple hospital EHR systems and clinical data warehouses across Europe, to enable a trial sponsor to predict the number of eligible patients for a candidate clinical trial protocol, to assess its feasibility and to locate the most relevant hospital sites.

The role of i~HD, as a not-for-profit Institute, is to provide independent governance oversight of such services now, and as these expand to connect with many more hospitals across Europe. The conference will present this platform and its pharma-led adoption programme, and detail the i~HD governance services that reflect state-of-the-art in the trustworthy re-use of health data for research. You will also learn about Europe's largest "big data" project in health: EMIF (European Medical Information Framework). The views of patients on the benefits of reusing their data for research will be presented by Mary Baker, past President of the European Brain Council, one of our keynote speakers.

For more information, please click here

Read more

Events Calendar

Biovision World Life Science Forum
From 13/04/2016 to 14/04/2016 (Lyon, France)

The Biovision World Life Science Forum is fostering a unique approach to meet and connect with, as well as collaborate between international decision-makers from the academic, civil society, policy-making and private sectors, whether industrial or investors.

Biovision 2016's pattern is dedicated to strengthening Action & Interaction for Innovation with:

  • A prospective part with a main theme on "Global health and Prevention" and specific paths (Medicine & Humanities, Vaccines, Cancer Prevention and Digitalised Patients) with workshops, plenary sessions and calls for action.
  • Catalyser & Investor parts with reinforced and segmented sourcing allowing more specific expertise for the evaluation and follow up of the projects, including financing.
Read more

What we are reading

What we are reading

A focus on patients - The Innovative Medicines Initiative in action
03 February 2016 (European Commission)

The Innovative Medicines Initiative (IMI) is the world’s largest public-private initiative in life sciences aiming to speed up the development of better and safer medicines. It brings together the latest research and cutting-edge technology to boost innovation and entrepreneurship in the pharmaceutical sector, to meet the challenges faced by patients and society as a whole. 

Read more

What we are reading

London launches new cancer drug development hub
03 February 2016 (Pharmafile)

Research charities, hospitals, and London boroughs have combined to launch a new global hub for cancer research and treatment in London, with the aim of accelerating the discovery of new treatments.

Read more

What we are reading

What the Dutch say and do not say about pharmaceuticals: a brief review of the Dutch Presidency priorities in the field of pharmaceuticals
04 February 2016 (FirstWorld Pharma)

The Dutch Presidency appears to be keeping its cards close to its chest as far as pharmaceuticals and public health are concerned. So far, they seem to have been purposefully ambiguous about their intentions and have not put forward any concrete proposals on the issues they highlight as priorities, namely anti-microbial resistance (AMR), pharmaceuticals, food product improvement, eHealth & innovation, dementia and medical devices.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail